0001209191-17-010023.txt : 20170213 0001209191-17-010023.hdr.sgml : 20170213 20170213163951 ACCESSION NUMBER: 0001209191-17-010023 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161231 FILED AS OF DATE: 20170213 DATE AS OF CHANGE: 20170213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INVACARE CORP CENTRAL INDEX KEY: 0000742112 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 952680965 STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 BUSINESS PHONE: 4403296000 MAIL ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ledda Ralf CENTRAL INDEX KEY: 0001690024 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15103 FILM NUMBER: 17599856 MAIL ADDRESS: STREET 1: ONE INVACARE WAY CITY: ELYRIA STATE: OH ZIP: 44035 5 1 doc5.xml FORM 5 SUBMISSION X0306 5 2016-12-31 0 0 0 0000742112 INVACARE CORP IVC 0001690024 Ledda Ralf ONE INVACARE WAY ELYRIA OH 44035 0 1 0 0 Sen VP/GM-EUR,Mid East&Africa Common Shares 25200 D Employee Stock Option (Right to Buy) Common Shares 14500 14500 D Includes 24,800 restricted stock units issued pursuant to the Invacare Corporation 2013 Equity Compensation Plan. 1,000 of these restricted stock units vest in full on May 15, 2017 after a three-year "cliff" vesting period; 800 of these restricted stock units vest in 1/2 increments on May 15, 2017 and May 15, 2018; 3,000 of these restricted stock units vest in 1/3 annual increments over three years commencing on May 15, 2017; and 20,000 of these restricted stock units vest in full on November 15, 2019 after a three-year "cliff" vesting period. No transaction is being reported on this line. Reported on a previously filed Form 3. The reporting person holds previously reported options to buy 14,500 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between August 22, 2007 and March 18, 2013, at exercise prices between $13.37 to $25.79 per share, will expire between August 22, 2017 and March 18, 2023, and became or will become exercisable between September 30, 2008 and March 31, 2017. /s/ Ralf Ledda, by Kristofer K. Spreen, his attorney-in-fact, pursuant to Power of Attorney, dated November 10, 2016, on file with the Commission 2017-02-13